XFOREST Therapeutics
Kyoto
About XFOREST Therapeutics
xFOREST Therapeutics provides technology platforms that integrate massively parallel biochemical analysis systems for species of RNA structures and in silico analysis pipelines. Their analyses include various RNA structures, regardless of their source organ, species, or virus.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $12.6M
- Funding stage: Early Stage Venture
- Last round: Series A (Jan 2025)
- Website: xforestx.com
- Phone: +81 75-708-8440
Industries & Categories
Biopharma, Biotechnology, Health Care, Life Science, Medical
Social Profiles
Canonical: https://fsome.com/organization/xforest-therapeutics-55565 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.